Eesti - eesti - Ravimiamet

accord healthcare b.v. - eplerenoon - õhukese polümeerikattega tablett - 50mg 30tk; 50mg 90tk; 50mg 28tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - eplerenoon - õhukese polümeerikattega tablett - 25mg 20tk; 25mg 10tk; 25mg 90tk; 25mg 30tk

Eesti - eesti - Ravimiamet

pfizer europe ma eeig - eplerenoon - õhukese polümeerikattega tablett - 25mg 20tk; 25mg 50tk; 25mg 10tk; 25mg 100tk; 25mg 200tk; 25mg 28tk; 25mg 30tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - eplerenoon - õhukese polümeerikattega tablett - 25mg 100tk; 25mg 20tk; 25mg 50tk; 25mg 10tk; 25mg 90tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - eplerenoon - õhukese polümeerikattega tablett - 50mg 10tk; 50mg 50tk; 50mg 28tk; 50mg 100tk; 50mg 20tk; 50mg 30tk

Eesti - eesti - Ravimiamet

pfizer europe ma eeig - eplerenoon - õhukese polümeerikattega tablett - 50mg 200tk; 50mg 100tk; 50mg 10tk; 50mg 90tk; 50mg 30tk; 50mg 20tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - reniini-angiotensiini süsteemi toimivad ained - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.

Euroopa Liit - eesti - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolaktoon - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.

Euroopa Liit - eesti - EMA (European Medicines Agency)

proveca pharma limited - enalapril (maleate) - südamepuudulikkus - reniini-angiotensiini süsteemi toimivad ained - treatment of heart failure.

Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.